Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11634486 Anti-SEZ6L2 antibodies and antibody drug conjugates

Patent 11634486 was granted and assigned to Bluefin Biomedicine on April, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Disclosed herein are anti-Seizure Related 6 Homolog Like 2 (SEZ6L2) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11634486 Anti-SEZ6L2 antibodies and antibody drug conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo